Skip to main content
. 2017 Jan 1;8(1):104–110. doi: 10.7150/jca.16856

Table 1.

Comparison of FR+-CTC with Established Tumor Biomarkers.

Lung cancer vs. benign disease AUC (95%CI)
FR+-CTC 0.7956 (0.7205-0.8708)
CEA 0.6289 (0.5371-0.7208)
NSE 0.5090 (0.4120-0.6061)
CYFRA21-1 0.5507 (0.4551-0.6462)
CEA+NSE+CYFRA21-1 0.6495 (0.5583-0.7406)
CEA+NSE+CYFRA21-1+ FR+-CTC 0.8267 (0.7601-0.8933)